Market focus DKP specializes in oncology, rare diseases, and cell and gene therapies, indicating vertical expertise ripe for expansion with biopharma clients seeking strategy across product lifecycles and reimbursement pathways.

Nimble, people-first As an employee-owned, small-to-mid sized firm, DKP can offer flexible engagement models, personalized service, and fast decision cycles to mid-stage and emerging biopharma companies seeking differentiated advisory support beyond larger consultancies.

Strong recognition DKP has prior recognition as a Best Places to Work in Indiana, signaling a positive employer brand that can attract top talent and enable scalable client delivery and knowledge continuity.

Tech-enabled delivery Utilization of tools like Power BI, Tableau, LinkedIn Ads, WordPress, and Mailchimp suggests capabilities in data-driven insights, marketing support, and client reporting that can be bundled into value propositions for market access and reimbursement projects.

Financial and growth potential Revenue range indicates a viable mid-market advisory partner with room for expansion through larger deals or multi-year engagements, particularly with biopharma players investing in market access, reimbursement strategy, and lifecycle planning.